Arkolith/Insider Trading/PMCB/Form 4

Abecassis Michael M

DirectorPharmaCyte Biotech, Inc. (PMCB) · full profile →Form 4 · filed Dec 12, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2025Grant(A)38K—$039K
Dec 12, 2025Tax withholding(F)17K$1.02$17K22K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 25, 2025Grant(A)63K—$063K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001683168-25-009112) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML